Philip A. Philip, MD, PhD, FRCP, FABC

Professor of Oncology, Pharmacology and Medicine
Kathryn Cramer Endowed Chair in Cancer Research
Vice President of Medical Affairs
Department of Oncology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

Dr. Philip Philip received his medical degree from the University of Baghdad, College of Medicine in Iraq, and his PhD in clinical pharmacology and pharmacogenetics at the University of London Guy’s Hospital Medical School in the UK. He completed a residency at the University of Baghdad, and a fellowship in medical oncology at the University of Oxford and the MD Anderson Cancer Center in Houston, Texas. Dr. Philip is Professor of Oncology, Pharmacology and Medicine, the Endowed Dr. Kathryn Cramer Professor of Cancer Research, as well as Vice President of Medical Affairs at the Karmanos Cancer Institute at Wayne State University School of Medicine in Detroit.

Dr. Philip is USA board-certified in medical oncology and is a fellow of the Royal College of Physicians in the UK. He is leader of hepatopancreatic biliary track, a member of planning committee of ASCO GI 2017, and chairs the pancreatic cancer committee at the Southwest Oncology Group (SWOG). In addition, he holds membership in the International Liver Cancer Association, American Pancreatic Association, American Society of Clinical Oncology, American Association for Cancer Research, and the Pharmacology and Molecular Mechanisms Group (PAMM) of the EORTC, among others.

A frequent national and international lecturer, Dr. Philip authored more than 200 manuscripts, review articles, editorials, and co-edited a book on pancreatic cancer. His major research interests are in the development of new therapies for gastrointestinal and neuroendocrine cancers with a special focus on pancreatic cancer. He has been the principal investigator on numerous local and national clinical trials in GI cancers.

Last modified: December 9, 2018